ARCHIVES

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

House, Senate Agree On $1.91 Billion NCI Appropriations

September 30, 1994